What is OneSource Specialty Pharma Ltd. Quarterly Revenue?

OneSource Specialty Pharma Ltd. Quarterly Revenue OneSource Specialty Pharma Sep-2026 Quarterly Revenue is Rs 515 Cr which is growth of 36.3% YoY.

What is OneSource Specialty Pharma Ltd. Quarterly Net Profit?

OneSource Specialty Pharma Ltd. Quarterly Net Profit OneSource Specialty Pharma Sep-2026 Quarterly Net Profit is Rs 86 Cr which is growth of 132.3% YoY.

What is OneSource Specialty Pharma Ltd. Annual Revenue?

OneSource Specialty Pharma Ltd. Annual Revenue OneSource Specialty Pharma Mar-2026 Annual Revenue is Rs 1,420 Cr which is growth of 7.8% YoY.

What is OneSource Specialty Pharma Ltd. Annual Net Profit?

OneSource Specialty Pharma Ltd. Annual Net Profit OneSource Specialty Pharma Mar-2026 Annual Net Profit is Rs 21 Cr which is growth of 9.8% YoY.

What is OneSource Specialty Pharma Ltd. Total Shareholders Fund?

OneSource Specialty Pharma Ltd. Total Shareholders Fund OneSource Specialty Pharma Mar-2026 Total Shareholders Fund is Rs 5,950 Cr which is growth of 0.5% YoY.

What is OneSource Specialty Pharma Ltd. Total Assets?

OneSource Specialty Pharma Ltd. Total Assets OneSource Specialty Pharma Mar-2026 Total Assets is Rs 8,276 Cr which is growth of 12.0% YoY.

What is OneSource Specialty Pharma Ltd. Book Value Per Share?

OneSource Specialty Pharma Ltd. Book Value Per Share OneSource Specialty Pharma Mar-2026 Book Value Per Share is 519 Rs which is growth of 0.3% YoY.

What is OneSource Specialty Pharma Ltd. ROE?

OneSource Specialty Pharma Ltd. ROE OneSource Specialty Pharma Mar-2026 ROE is 0% which is growth of 0.0% YoY.

What is OneSource Specialty Pharma Ltd. Cash From Operating Activity?

OneSource Specialty Pharma Ltd. Cash From Operating Activity OneSource Specialty Pharma Mar-2026 Cash From Operating Activity is Rs 55 Cr which is growth of 216.7% YoY.

What is OneSource Specialty Pharma Ltd. Net Cash Flow?

OneSource Specialty Pharma Ltd. Net Cash Flow OneSource Specialty Pharma Mar-2026 Net Cash Flow is Rs -61 Cr which is growth of -187.8% YoY.

OneSource Specialty Pharma Ltd.

NSE: ONESOURCE | BSE: 544292

Momentum Trap

Download real time

US FDA Inspections ANDA Approvals

-4.80(-0.31%)

47.42% Gain from 52W Low

347.9K

NSE+BSE Volume

High vol.+gain this week

NSE 02 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

OneSource Specialty Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for OneSource Specialty Pharma share price target, revenues, EPS, net income and more

OneSource Specialty Pharma quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue OneSource Specialty Pharma Sep-2026 Quarterly Revenue is Rs 515 Cr which is growth of 36.3% YoY.
POSITIVE
Quarterly Net Profit OneSource Specialty Pharma Sep-2026 Quarterly Net Profit is Rs 86 Cr which is growth of 132.3% YoY.

OneSource Specialty Pharma Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Sep '26	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23
TOTAL_SR_Q Total Rev. ⌄	515.4	450.3	421.1	294.8	378.2	326.3	481.3	341.8	249.7	244	75.8	57.3
SR_Q Operating Rev.	514.5	446.5	419	290.2	375.2	321	477.4	336.8	245.4	240	73.1	56.2
OI_Q Other Income	0.9	3.8	2.1	4.6	3	5.3	3.9	5	4.3	4	2.6	1.1
OEXPNS_Q Operating Exp.	356	332.3	344.3	277.4	273.6	241.1	240.5	236.4	223.2	229.8	75.8	66.5
OEXPNS_Q Operating Exp.	356	332.3	344.3	277.4	273.6	241.1	240.5	236.4	223.2	229.8	75.8	66.5
OP_Q Operating Profit	158.5	114.1	74.7	12.8	101.6	79.9	237	100.4	22.2	10.3	-2.7	-10.3
OPMPCT_Q Operating Profit Margin %	30.81%	25.56%	17.83%	4.42%	27.07%	24.88%	49.63%	29.81%	9.04%	4.27%	-3.65%	-18.40%
DEP_Q Depr.	39	36.2	34.7	34.6	34.2	33.3	33.6	34	33.4	33.5	19.5	19.5
INT_Q Interest	34.2	30.5	22.3	38	33.3	27	32.4	43.9	44.1	41.2	20.4	26
PBT_Q Profit Before Tax	86.2	51.2	21.5	-62.2	37.1	24.8	174.9	-73	-57.9	-65.4	-40	-160.6
TAX_Q Tax										-41.5
NP_Q Net Profit	86.2	51.2	21.5	-62.2	37.1	24.8	174.2	-73	-57.9	-24	-40	-130
EPS_adj_Q EPS Adj. latest	7.5	4.5	1.9	-5.4	3.2	2.2	15.2	-6.4	-5.1	-2.1	-3.5	-11.3
NP_TTM Net profit TTM	96.7	47.6	21.2	173.9	163.1	68.1	19.3	-194.9	-251.9	-	-	-
EPS_TTM Basic EPS TTM	8.4	4.2	1.9	15.2	14.2	6	1.7	-17	-60.6	-	-	-
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes		Notes	Notes	Notes	Notes	Notes		Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

OneSource Specialty Pharma competitor comparison and performance snapshot within industry

OneSource Specialty Pharma revenue mix: sales, profit, and capital employed breakups by segment

OneSource Specialty Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue OneSource Specialty Pharma Mar-2026 Annual Revenue is Rs 1,420 Cr which is growth of 7.8% YoY.
POSITIVE
Annual Net Profit OneSource Specialty Pharma Mar-2026 Annual Net Profit is Rs 21 Cr which is growth of 9.8% YoY.

OneSource Specialty Pharma Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
SR_A Total Rev. Ann. ⌄	224.9%	1,681.6	1,420.4	1,317.3	176.1	41.4	131.9
TotalOperatingRevenues_A Operating Rev. Ann.	231.2%	1,670.1	1,405.4	1,299.6	171.9	38.7	128.2
OI_A Other Income Ann.	77.1%	11.4	15	17.7	4.2	2.7	3.7
OEXPNS_A Operating Exp. Ann.	78.6%	1,310	1,136.4	930.3	260.2	199.4	132.2
OEXPNS_A Operating Exp. Ann.	78.6%	1,310	1,136.4	930.3	260.2	199.4	132.2
OP_A Operating Profit Ann.	-	360.2	269	369.3	-88.2	-160.7	-4
OPMPCT_A OPM Ann. %	-		18.94%	28.03%	-50.09%	-388.08%	-3.04%
TotalExpenses_A Total Exp. Ann. ⌄	64.6%		1,393.8	1,226.5	425.9	312.6	231.8
OtherExpenses_A Other Exp. Ann.	62%	745.5	451.4	307.3	110.3	106.2	73.9
EmployeeBenefitExpenses_A Employee Exp. Ann.	48.9%	271.4	240.5	214.8	79.4	72.8	53.4
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-
CostOfFuel_A Cost Of Fuel Ann.	-
EBIDT_A EBITDA Ann.	-		284	387	-84	-158	-0.3
EBIDTPCT_A EBITDA Ann. margin %	-		19.99%	29.38%	-47.70%	-381.58%	-0.26%
INT_A Interest Ann.	36.4%	124.9	120.6	161.7	89.5	47.5	46.5
DEP_A Depr.	27.7%	144.5	136.8	134.5	76.3	65.7	53.1
PBT_A PBT Ann.	-	96.7	21.2	-21.5	-365.7	-415.6	-99.9
TAX_A Tax Ann.	-			-41.5			-0.1
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	-		21.2	20	-365.7	-415.6	-99.8
IncomeMinorityInterest_A Minority Interest Income Ann.	-		-	-	-	-	-
NP_A Net Profit Ann.	-	96.7	21.2	19.3	-391.2	-799.8	-231.2
NETPCT_A NPM Ann. %	-		1.50%	1.48%	-227.52%	-2,065.99%	-180.34%
EPS_adj_A EPS Adj. latest Ann.	-		1.9	1.7	-34.1	-69.8	-20.2
result_notes Result Notes			Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

7.8%

2Y CAGR

184%

3Y CAGR

224.9%

Net Profit Ann.

1Y CHG

9.8%

Operating Exp. Ann.

1Y CHG

22.2%

2Y CAGR

109%

3Y CAGR

78.6%

OneSource Specialty Pharma balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund OneSource Specialty Pharma Mar-2026 Total Shareholders Fund is Rs 5,950 Cr which is growth of 0.5% YoY.
POSITIVE
Total Assets OneSource Specialty Pharma Mar-2026 Total Assets is Rs 8,276 Cr which is growth of 12.0% YoY.

OneSource Specialty Pharma Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	96.4%	5,949.6	5,920.1	395.7	785.5	1,012.5
EQCAP_A Equity Share Capital Ann.	42.2%	11.5	11.4	4	4	3
TotalShareCapital_A Total Share Capital Ann.	42.2%	11.5	11.4	4	4	3
ReservesAndSurplus_A Reserves Plus Surplus Ann.	96.6%	5,938.2	5,908.7	391.7	781.4	1,009.4
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	96.6%	5,938.2	5,908.7	391.7	781.4	1,009.4
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	30.8%	801.9	400.9	282.3	358.1	621.2
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	118.5%	220	165.8	8.3	21.1	21.8
CL_A Total Current Liabilities Ann. ⌄	20.8%	1,523.9	1,069.5	630.6	865.2	808.7
TradePayables_A Trade Payables Ann.	61.8%	401.9	160.1	81	94.8	62.5
OtherCurrentLiabilities_A Other Current Liabilities Ann.	14.4%	396.6	345	254.7	265	185.8
ShortTermProvisions_A ST Provisions Ann.	52.6%	12.8	12.2	4.3	3.6	3.3
TL_A Total Capital Plus Liabilities Ann.	60.3%	8,276.1	7,390.5	1,308.6	2,008.8	2,442.4
FixedAssets_A Fixed Assets Ann. ⌄	29.3%	3,666.2	3,406.2	1,050.6	1,695.8	1,720.8
TangibleAssets_A Tangible Assets Ann.	-7.4%	925.9	897.4	682.4	1,166.9	1,226.9
IntangibleAssets_A Intangible Assets Ann.	126.9%	2,271.7	2,302.9	180.2	194.5	4.3
CapitalWorkInProgress_A Capital Work In Progress Ann.	18%	313.9	60.4	42.7	191.2	67.8
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	56.5%	6,819	6,366.6	1,132.2	1,780.4	1,931.3
NonCurrentInvestments_A Non Current Investments Ann.	-	2,925.7	2,839.2	3.8
DeferredTaxAssets_A Deferred Tax Assets Ann.	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	39%	227.2	121.2	77.8	84.6	210.4
CA_A Total Current Assets Ann. ⌄	85.5%	1,457	1,023.9	176.4	228.4	511.1
CurrentInvestments_A Current Investments Ann.	6.9%	5.5	8.9	15.8	4.5
TradeReceivables_A Trade Receivables Ann.	478.4%	735.2	442	55.2	3.8	23.6
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	4.1%	90	227.6	60.3	79.8	169.7
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-
OtherCurrentAssets_A Other Current Assets Ann.	197.7%	187.4	192	33.8	7.1	42.2
TA_A Total Assets Ann.	60.3%	8,276.1	7,390.5	1,308.6	2,008.8	2,442.4
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-38.1%	283.5	58.5	1,155.7	1,193	150.2
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	2,925.7	2,839.2	3.8
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

12%

2Y CAGR

151.5%

3Y CAGR

60.3%

Total Current Liabilities Ann.

1Y CHG

42.5%

2Y CAGR

55.5%

3Y CAGR

20.8%

Total ShareHolders Funds Ann.

1Y CHG

0.5%

2Y CAGR

287.8%

3Y CAGR

96.4%

OneSource Specialty Pharma ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share OneSource Specialty Pharma Mar-2026 Book Value Per Share is 519 Rs which is growth of 0.3% YoY.
POSITIVE
ROE OneSource Specialty Pharma Mar-2026 ROE is 0% which is growth of 0.0% YoY.

OneSource Specialty Pharma Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
BVSH_A BVSH Ann.	38.4%	519.1	517.4	98.7	195.9	333.5
ROA_A RoA Ann. %	-	0.25%	0.26%	-29.89%	-39.81%	-9.46%
ROE_A ROE Ann. %	-	0.35%	0.32%	-98.85%	-101.83%	-22.83%
ROCE_A ROCE Ann. %	-	2.18%	3.99%	-23.64%	-19.55%	-3.26%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-	20.20%	29.77%	-48.86%	-408.10%	-0.26%
PBITMargin_A EBIT Ann. Margin %	-	10.47%	19.42%	-93.24%	-577.76%	-41.66%
PBTMargin_A PBT Ann. Margin %	-	1.50%	-1.65%	-212.71%	-1,073.62%	-77.94%
NETPCT_A NPM Ann. %	-	1.50%	1.48%	-227.52%	-2,065.99%	-180.34%
ASETTO_A Asset Turnover Ann. %	-	0.2	0.3	0.1	0	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	49.4%	1	1	0.3	0.3	0.6
QuickRatio_A Quick Ratio Ann.	91.3%	0.7	0.8	0.3	0.1	0.3
DividendPayoutNP_A Dividend Payout to NP Ann.	-			-	-	-
EarningRetention_A Earning Retention Ann. %	-
CashEarningRetention_A Cash Earning Retention Ann. %	-
CashEarningRetention_A Cash Earning Retention Ann. %	-
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	-	18,062.4	20,546.9
EVPerNetSales_A EV Per Net Sales Ann.	-	12.9	15.8	-	-	-
PBV_A Price To Book Value Adjusted	-27.8%	3	3.53	3.52	7.96	4.67
EVPerEBITDA_A EV Per EBITDA Ann.	-	63.6	53.1	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	-	12	15.4	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-
EYield_A Earnings Yield Ann.	-
DEBT_CE_A Total Debt to Total Equity Ann.	-43.3%	0.2	0.1	1.4	1.1	1.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

9.4%

RoA Ann. %

1Y CHG

-3.8%

Current Ratio Ann.

2Y CAGR

82.6%

3Y CAGR

49.4%

OneSource Specialty Pharma cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity OneSource Specialty Pharma Mar-2026 Cash From Operating Activity is Rs 55 Cr which is growth of 216.7% YoY.
NEGATIVE
Net Cash Flow OneSource Specialty Pharma Mar-2026 Net Cash Flow is Rs -61 Cr which is growth of -187.8% YoY.

OneSource Specialty Pharma Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
CFO_A Cash from Operating Act. Ann. ⌄	-	55.2	-47.3	-107.2	-162.9	-415.9
PBT_A PBT Ann.	-	21.2	-21.5	-365.7	-415.6	-99.9
INT_A Interest Ann.	36.4%	120.6	161.7	89.5	47.5	46.5
TAX_A Tax Ann.	-		-41.5			-0.1
CFI_A Cash from Investing Act. Ann.	-	-477.6	-300	510.5	-67.7	-691.6
CFA_A Cash from Financing Act. Ann.	45.1%	361.1	417.2	-390.5	118.3	1,162
NCF_A Net Cash Flow Ann. ⌄	-	-61.4	69.9	12.8	-112.3	54.5
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-8.9%	92.1	22.2	9.5	121.8	67.3
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	47.8%	30.7	92.1	22.3	9.5	121.8

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Financing Act. Ann.

1Y CHG

-13.4%

3Y CAGR

45.1%

OneSource Specialty Pharma investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Revenue Mix
Annual
Balance Sheet
Ratios
Cash Flow
Documents

OneSource Specialty Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

OneSource Specialty Pharma - Forecaster

Forecaster Analyst Estimates for OneSource Specialty Pharma share price target, revenues, EPS, net income and more